Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
Key Takeaways
- Full and open competition - all businesses eligible to bid
- Work to be performed in ABERDEEN PROVING GROU, MD
- Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Contract Details
- Notice ID
- W911SR-25-S-GUIDE
- Opportunity Type
- Special Notice
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEPT OF THE ARMY
- Office
- W6QK ACC-APG
- Posted Date
- Monday, December 1, 2025
- Response Deadline
- Wednesday, October 18, 2028
- PSC Code
- AC13
- Set-Aside
- Full & Open Competition
- Place of Performance
- ABERDEEN PROVING GROU, MD, 21010-5424
- Status
- Active
Description
W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generative Unconstrained Intelligence Drug Engineering (GUIDE) is an integrated computational and experimental platform designed to accelerate medical countermeasure development. GUIDE harnesses the power of advanced simulation and machine learning to enable preparedness and facilitate rapid response to protect the warfighter from a diverse and dynamic threat
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) in ABERDEEN PROVING GROU, MD.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
